Global Anti-Infective Agents Market Report, Size, Share, Analysis 2017 and Forecast to 2023.

Jan 3, 2018

According to Stratistics MRC,the Global Anti-Infective Agents Market is accounted for $86.7 billion in 2016 and expected to grow at a CAGR of 3.8% to reach $113.16 billion by 2023.

Gaithersburg, Maryland, United States - January 3, 2018 /MarketersMedia/ —

Rising incidences of infectious diseases such as HIV, H1N1, and Ebola virus, awareness amongst the patients, commercialization of pipeline products, Govt collaborating with pharmaceutical companies for the development of new agents, development of new multi-drug resistance against micro-organisms are boosting the market growth. Treatment rates for communicable diseases in developing countries and treatment of Community Acquired Bacterial Pneumonia (CABP) are expected to impart the market growth. Growing resistance of infection to the drug therapies, high price of drugs, competition between generic manufacturers and perilous reimbursement policies will impede market growth.

Request for sample here: http://www.strategymrc.com/report/anti-infective-agents-market-2017/request-sample

Based on Product, most of the Antibacterial agents are in pipeline for the modifications of existing antibiotic classes. More innovative products are required against pathogens with no cross- or co-resistance to existing classes. Many of the products in the clinical pipeline are already funded by research grants from public and philanthropic institutions.For instance, Delafloxacin was approved by the US Food and Drug Administration on 21 June 2017.

Access the complete report at: http://www.strategymrc.com/report/anti-infective-agents-market-2017

North America commanded the anti-infective agents market and is followed by Europe. Asia Pacific is the fastest growing market due to improvements in healthcare infrastructure, demand for drugs and ongoing government initiatives for various control programs.

Some of the key players in Global Anti-Infective Agents market are Pfizer Ltd, Ranbaxy Laboratories Ltd, Sun Pharmaceutical Industries Ltd., AstraZeneca Plc, Boehringer Ingelheim, Bristol-Myers Squibb Co, Abbott Laboratories, Bayer Healthcare AG, Cipla Ltd, GlaxoSmithKline Pharmaceuticals Ltd, Merck & Co., Inc, Novartis AG, Glenmark Pharmaceuticals Ltd, Lupin Ltd, Panacea Biotech Ltd and Claris Life Sciences Ltd.

Make an inquiry at: http://www.strategymrc.com/report/anti-infective-agents-market-2017

Products Covered:
• Antifungal agents
• Antiviral agents
• Antituberculosis agents
• Antitreponemal agents
• Vaccines
• Antibacterial agents

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Follow us on Twitter: https://twitter.com/StratisticsMRC

Follow us on LinkedIn at: https://www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile

About Stratistics MRC
We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.

Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.

Contact Info:
Name: James Lamb
Email: Send Email
Organization: Stratistics Market Research Consulting Pvt Ltd

Source URL: https://marketersmedia.com/global-anti-infective-agents-market-report-size-share-analysis-2017-and-forecast-to-2023/283274

For more information, please visit http://www.strategymrc.com/

Source: MarketersMedia

Release ID: 283274

More News

Vietjet’s domestic ambitions dealt a blow after court orders global asset freeze
Oct 19, 2026
Vietjet’s domestic ambitions dealt a blow after court orders global asset freeze

The order comes after a long-running battle with an investment firm seeking back payment for the use of four planes by the airline.

Nightmare on Wall Street: The AI alarm bells are ringing louder
Oct 19, 2026
Nightmare on Wall Street: The AI alarm bells are ringing louder

The implosion in the share price of one neocloud company has highlighted just how vulnerable Wall Street is.

Lachlan treasure chest draws fresh wave of NSW mining hopefuls
Oct 19, 2026
Lachlan treasure chest draws fresh wave of NSW mining hopefuls

NSW’s Lachlan Fold Belt is back in the junior explorer spotlight, with a string of newcomers chasing the next big copper-gold discovery, including recent stalwart Kuniko Limited.

ASX creeps higher after dodging AI volatility; energy shares jump
Oct 19, 2026
ASX creeps higher after dodging AI volatility; energy shares jump

The Australian sharemarket has made a bright start to the week, as a rebound in the local banks continues.

The ‘Ozempic face’ discovery that revived a fading giant
Oct 19, 2026
The ‘Ozempic face’ discovery that revived a fading giant

A surprise discovery may have saved one of the world’s oldest chemical companies from sliding into irrelevance.

Stax is back, saved by founders of sneakerhead marketplace
Oct 18, 2026
Stax is back, saved by founders of sneakerhead marketplace

The athleisure brand collapsed in June after an ill-fated retail expansion, but now a new entrepreneurial couple plans to revive it.

Australia clashes with Asian energy giants over gas export crackdown
Oct 18, 2026
Australia clashes with Asian energy giants over gas export crackdown

Labor is risking a backlash from major Asian partners as it forges ahead with contentious rules to divert more gas exports to local consumers.

‘Only the sharks are left’: The $388 billion change shaking up the sharemarket
Oct 18, 2026
‘Only the sharks are left’: The $388 billion change shaking up the sharemarket

There’s been a major shift in how Australians buy shares, sparking debate over whether our market is becoming more prone to wild swings – or even the risk of bubbles.

Trying to find a job is now as toxic as dating apps. I want a career, not a booty call
Oct 18, 2026
Trying to find a job is now as toxic as dating apps. I want a career, not a booty call

Recruiters, your “booty calls” are wearing thin. And it’s time to give up the “ghost”.

Drones as first responders: welcome to the future of policing
Oct 18, 2026
Drones as first responders: welcome to the future of policing

Drones have a bird’s-eye view of the city. The prospect of police departments integrating drones into their workflow raises questions about privacy and police accountability.

The $38b battle for Australia’s top gold miner may be just beginning
Oct 18, 2026
The $38b battle for Australia’s top gold miner may be just beginning

A South African mining giant is seeking to rally investors across Australia to pressure a major local rival into takeover talks.

Weighing the real cost of migration cuts
Oct 17, 2026
Weighing the real cost of migration cuts

An analysis using Parliamentary Budget Office tools shows that One Nation’s immigration policy may add an extra $275 billion to national debt.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.